Hints and tips:
Related Special Reports
...guidance from the Centers for Medicare and Medicaid Services (CMS)....
...Instead, only about 5,600 patients had been approved for treatment by early April, according to a registry by the Centers for Medicare & Medicaid Services shared with the Financial Times....
...The Centers for Medicare & Medicaid Services said last month that Medicare Part D drug benefit plans will cover weight loss medicines when they are approved to treat a separate medical problem, such as heart...
...like Medicaid and Medicare....
...The drugs on the list cost Medicare more than $50bn in the 12 months to May 31, said the Centers for Medicare and Medicaid Services....
...The pharmaceutical company said on Tuesday it had filed suit against the US Department of Health and Human Services and Centers for Medicare and Medicaid Services....
...“It marks to me a deep hypocrisy,” said Don Berwick, a former administrator of the US Centers for Medicare and Medicaid, who resigned as a member of Roivant’s advisory board in 2021....
...The pharmaceutical company said on Tuesday it filed a lawsuit against the US Department of Health and Human Services as well as the Centers for Medicare and Medicaid over what it calls an “innovation-damaging...
...The process is due to begin in earnest next week when the Centers for Medicare & Medicaid Services (CMS) is due to publish a list of 10 expensive drugs that will be the focus of the negotiation....
...The decision by the Centers for Medicare & Medicaid Services to provide coverage for the treatment is crucial to enable a wide rollout....
...The Centers for Medicare & Medicaid Services did not respond to a request for comment....
...The company said a decision by Centers for Medicare and Medicaid Services to restrict financial support for Leqembi to Alzheimer’s patients whose doctors participate in a health agency database could have...
...“This is not the Vivek that I knew,” said Don Berwick, a former administrator of the US Centers for Medicare and Medicaid, who resigned as a member of Roivant’s advisory board in 2021....
...The process is due to begin in earnest in September when the Centers for Medicare & Medicaid Services (CMS) is due to identify 10 expensive drugs that will be the focus of the negotiation....
...for Medicare and Medicaid Services, a US government agency, last week....
...In the wake of the controversy over the FDA approval of Biogen’s aducanumab, the US Centers for Medicare and Medicaid Services said only patients taking part in a clinical trial would benefit from reimbursement...
...Cheung said Eisai would apply for full approval for Leqembi imminently and talk to the US Centers for Medicare & Medicaid Services about relaxing reimbursement restrictions for the treatment....
...One of its biggest setbacks was the disastrous launch of aducanumab, which prompted the US Centers for Medicare & Medicaid Services to severely restrict reimbursement for all amyloid-reducing monoclonal...
...And there are gaps in access for those on Medicaid, a joint state and federal insurance scheme that provides free or less expensive cover to low-income families....
...“Based on these data, we are highly confident in lecanemab’s approval and eventual Centers for Medicare and Medicaid Services (CMS) reimbursement,” he said....
...In a draft decision published on Tuesday, the Centers for Medicare & Medicaid Services said its thorough review process that found that while there may be potential for promise with the treatment, there...
...The Centers for Medicare & Medicaid Services issued a formal decision on Thursday limiting reimbursement for Biogen’s drug to just a few thousand patients enrolled in clinical trials rather than the estimated...
...The unusual price cut comes as the US Centers for Medicare and Medicaid Services is considering whether to cover the drug in Medicare, the programme for senior citizens....
...Strict curbs put on Biogen’s Alzheimer’s treatment The Centers for Medicare & Medicaid Services has upheld an earlier draft ruling restricting access to Biogen’s Alzheimer’s treatment Aduhelm....
International Edition